Ajanta Pharma Launches Met XL AMT 25 mg a triple FDC for Uncontrolled Hypertension with CAD Deeksha Bhandari20 Jun 2025 12:00 PM ISTIn a first move Ajanta pharma one of the leaders in the cardiology segment, has announced the launch of Met XL AMT 25 mg. It is a triple-drug...
Ajanta Pharma Launches World's 1st FDC Met XL AMT for Patients with Uncontrolled Hypertension and Cardiovascular Co-morbidity in India MD Brand Connect8 Aug 2023 11:53 AM ISTAjanta Pharma, one of the leaders in the cardiology segment has announced the launch of Met XL AMT, a novel triple drug combination for the...
Physician's opinion on Metoprolol in CVD: The master of all trades! dr. Abhimanyu Uppal11 Feb 2022 11:45 AM ISTIt will not be an overstatement that cardioselective beta-blocker metoprolol has been one of the most researched and at the same time most widely used...
Bombay HC restrains firm from infringing Sun Pharma trademark Prolomet Roshni Dhar28 Oct 2021 2:00 PM ISTThe Bombay High Court has noted an ad-interim injunction restraining the Salud Care (India) Private from using trademark PROLOMEK or any other...
Bombay HC restrains firm from infringing Sun Pharma trademark Prolomet Medical Dialogues Team23 Oct 2021 5:54 PM ISTNew Delhi: The Bombay High Court has noted an ad-interim injunction restraining the Salud Care (India) Private from using trademark PROLOMEK or any...
